These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 1966885)
1. Clinical and laboratory precautions that reduce the adverse reactions, alloimmunization, infectivity, and possibly immunomodulation associated with homologous transfusions. Wenz B Transfus Med Rev; 1990 Oct; 4(4 Suppl 1):3-7. PubMed ID: 1966885 [No Abstract] [Full Text] [Related]
2. Dual reduction in the immunologic and infectious complications of transfusion by filtration/removal of leukocytes from donor blood soon after collection. Rawal BD; Davis RE; Busch MP; Vyas GN Transfus Med Rev; 1990 Oct; 4(4 Suppl 1):36-41. PubMed ID: 2134639 [No Abstract] [Full Text] [Related]
3. Canadian Red Cross Society symposium on leukodepletion: report of proceedings. Freedman JJ; Blajchman MA; McCombie N Transfus Med Rev; 1994 Jan; 8(1):1-14. PubMed ID: 7907899 [No Abstract] [Full Text] [Related]
4. Characterization of reactions after exclusive transfusion of white cell-reduced cellular blood components. Dzieczkowski JS; Barrett BB; Nester D; Campbell M; Cook J; Sugrue M; Andersen JW; Anderson KC Transfusion; 1995 Jan; 35(1):20-5. PubMed ID: 7998063 [TBL] [Abstract][Full Text] [Related]
5. [Efficacy of leukocyte-depleted platelet concentrates for prevention of HLA-alloimmunization in patients with frequent platelet transfusions: a prospective multi-institutional study using a polyester platelet filter]. Handa M; Ikeda Y; Kurata Y; Tsubaki K; Horiuchi A; Furihata K; Kimura Y; Toyama K; Takamoto S; Tsukimoto I Rinsho Ketsueki; 1992 Apr; 33(4):451-60. PubMed ID: 1602608 [TBL] [Abstract][Full Text] [Related]
9. Prevention of primary transfusion-associated cytomegalovirus infection in bone marrow transplant recipients by the removal of white cells from blood components with high-affinity filters. van Prooijen HC; Visser JJ; van Oostendorp WR; de Gast GC; Verdonck LF Br J Haematol; 1994 May; 87(1):144-7. PubMed ID: 7947238 [TBL] [Abstract][Full Text] [Related]
10. Clinical effects of leucoreduction of blood transfusions. Bilgin YM; van de Watering LM; Brand A Neth J Med; 2011 Oct; 69(10):441-50. PubMed ID: 22058263 [TBL] [Abstract][Full Text] [Related]
11. Transfusion-associated noncardiogenic pulmonary edema. Herman JH; Kamel H Transfusion; 1987; 27(3):293. PubMed ID: 3590296 [No Abstract] [Full Text] [Related]
12. Universal leukocyte reduction: Is it appropriate medical practice or not? Angelbeck JH; Ortolano GA J Infus Nurs; 2005; 28(4):273-81. PubMed ID: 16106211 [TBL] [Abstract][Full Text] [Related]
14. HLA antigens on leukocyte fragments and plasma proteins: prestorage leukoreduction by filtration. Dzik S; Szuflad P; Eaves S Vox Sang; 1994; 66(2):104-11. PubMed ID: 8184591 [TBL] [Abstract][Full Text] [Related]
15. Universal WBC reduction: the case for and against. Vamvakas EC; Blajchman MA Transfusion; 2001 May; 41(5):691-712. PubMed ID: 11346708 [No Abstract] [Full Text] [Related]
16. [Leukocyte depletion of blood products. Indications and technical implementation]. Böck M; Heim MU Fortschr Med; 1995 Mar; 113(8):102-4. PubMed ID: 7759031 [TBL] [Abstract][Full Text] [Related]
19. Indications for the use of cytomegalovirus-seronegative blood products. Preiksaitis JK Transfus Med Rev; 1991 Jan; 5(1):1-17. PubMed ID: 1666324 [No Abstract] [Full Text] [Related]
20. Lymphocyte contamination in leukocyte-depleted red cell and platelet concentrates obtained by filtration. Müller N; Gummelt M; Osskop S; Schlake C Haematol Blood Transfus; 1990; 33():563-5. PubMed ID: 2323656 [No Abstract] [Full Text] [Related] [Next] [New Search]